Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    526139.BO Net Margin

    As of 2025-05-22, the Net Margin of Transgene Biotek Ltd (526139.BO) is -279.1%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    526139.BO Net Margin - Historical Value
    DateValue
    2024-03-31 -279.1%
    2023-03-31 -10907.9%
    2022-03-31 -11998.4%
    2021-03-31 -6154.3%
    2020-03-31 -306636%
    2019-03-31 -12334.2%
    2018-03-31 -5445.2%
    2017-03-31 -7071.7%
    2016-03-31 -11864.4%
    2015-03-31 -5750.4%
    526139.BO Net Margin - Peers Comparison
    TickerNameValue
    180400.KQDx & Vx Co Ltd-138.6%
    215600.KQSillaJen Inc-675.5%
    235980.KQMedPacto Inc-
    284620.KQKainos Medicine Inc-5699.3%
    299660.KQCellid Co Ltd-294.3%
    4575.TCanBas Co Ltd-487.4%
    4884.TKringle Pharma Inc-945.1%
    524663.BOBharat Immunologicals and Biologicals Corporation Ltd-38.2%
    532039.BOZenotech Laboratories Ltd13%
    532905.BOSaamya Biotech (India) Ltd-3.1%
    ACW.AXActinogen Medical Ltd-4482.3%
    ATX.AXAmplia Therapeutics Ltd-101.5%
    BIT.AXBiotron Ltd-208.9%
    CDY.AXCellmid Ltd-58.2%
    DXB.AXDimerix Ltd-2926.4%
    HDST.TAHBL Hadasit Bio Holdings Ltd-96934.8%
    HXL.AXHexima Ltd-1514.3%
    IVQ.AXInvitrocue Ltd-1230.6%
    KDST.TAKadimastem Ltd-3132.7%
    LCT.AXLiving Cell Technologies Ltd-57398.8%
    NSB.AXNeuroScientific Biopharmaceuticals Ltd13.6%
    NXTG.TANextage Therapeutics Ltd-442.8%
    SCU.AXStemcell United Ltd-25.7%
    TDL.AXTBG Diagnostics Ltd-76.6%
    VBS.AXVectus Biosystems Ltd-3042.1%
    XTLB.TAX T L Biopharmaceuticals Ltd-104.6%
    Tickers added to watchlist